CoChat

Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1

Open access
Romero, Rodrigo, Sánchez-Rivera, Francisco J., Westcott, Peter M. K., Mercer, Kim L., Bhutkar, Arjun, Muir, Alexander, González Robles, Tania J., Lamboy Rodríguez, Swanny, Liao, Laura Z., Ng, Sheng Rong, Li, Leanne, Colón, Caterina I., Naranjo, Santiago, Beytagh, Mary Clare, Lewis, Caroline A., Hsu, Peggy P., Bronson, Roderick T., Vander Heiden, Matthew G., Jacks, Tyler · 2020 · Nature Cancer
Cited by 75

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Approximately 20–30% of human lung adenocarcinomas (LUADs) harbor mutations in Kelch-like ECH-associated protein 1 (KEAP1) that hyperactivate the nuclear factor, erythroid 2-like 2 (NFE2L2) antioxidant program. We previously showed that Kras-driven Keap1-mutant LUAD is highly aggressive and dependent on glutaminolysis. Here we performed a druggable genome CRISPR screen and uncovered a Keap1-mutant-specific dependency on solute carrier family 33 member 1 (Slc33a1), as well as several functionally related genes associated with the unfolded protein response. Genetic and biochemical experiments using mouse and human Keap1-mutant tumor lines, as well as preclinical genetically engineered mouse models, validate Slc33a1 as a robust Keap1-mutant-specific dependency. Furthermore, unbiased genome-wide CRISPR screening identified additional genes related to Slc33a1 dependency. Overall, our study provides a rationale for stratification of patients harboring KEAP1-mutant or NRF2-hyperactivated tumors as likely responders to targeted SLC33A1 inhibition and underscores the value of integrating functional genetic approaches with genetically engineered mouse models to identify and validate genotype-specific therapeutic targets. A druggable genome CRISPR-Cas9 screen followed by functional validation in preclinical lung cancer models uncovers Slc33a1 as a Keap1-mutant-specific targetable dependency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-020-0071-1

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 75

Metadata

Authors
Romero, R., Sánchez-Rivera, F. J., Westcott, P. M. K., Mercer, K. L., Bhutkar, A., Muir, A., González Robles, T. J., Lamboy Rodríguez, S., Liao, L. Z., Ng, S. R., Li, L., Colón, C. I., Naranjo, S., Beytagh, M. C., Lewis, C. A., Hsu, P. P., Bronson, R. T., Vander Heiden, M. G., & Jacks, T.
Venue
Nature Cancer
Published
2020-06-08
Volume
1
Issue
6
Pages
589-602
ISSN
2662-1347 (ISSN-L)
OpenAlex
W3033153720
Cited by
75
References
28
FWCI
3.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1. https://app.cochat.ai/papers/10.1038/s43018-020-0071-1
The paper
Romero, R., Sánchez-Rivera, F. J., Westcott, P. M. K., Mercer, K. L., Bhutkar, A., Muir, A., González Robles, T. J., Lamboy Rodríguez, S., Liao, L. Z., Ng, S. R., Li, L., Colón, C. I., Naranjo, S., Beytagh, M. C., Lewis, C. A., Hsu, P. P., Bronson, R. T., Vander Heiden, M. G., & Jacks, T. (2020). Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1. Nature Cancer. https://doi.org/10.1038/s43018-020-0071-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.